Early circulating tumor DNA (ctDNA) changes during treatment with immune checkpoint inhibitors (ICI) as a predictor of clinical outcomes in patients (pts) with advanced stage melanoma/skin cancer.
Autor: | Ma, Vincent T., Park, Yeonhee, Patel, Janmesh. D, Harris, Madison S., Mannino, Matthew C., Schehr, Jennifer L., Birbrair, Alexander, Zhao, Shuang, Lang, Joshua Michael |
---|---|
Zdroj: | Journal of Clinical Oncology; 2024 Supplement, Vol. 42, p225-225, 15p |
Databáze: | Supplemental Index |
Externí odkaz: |